ROIV - Roivant Sciences Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$36.17
DETAILS
HIGH:
$42.00
LOW:
$30.00
MEDIAN:
$37.00
CONSENSUS:
$36.17
UPSIDE:
20.73%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 8.3 | 29.1 | 32.7 | 31.5 | 55.3 | 23.8 | 67.7 |
| Cost of Revenue | 1.3 | 0.9 | 1.6 | 3.0 | 9.0 | 2.1 | 1.1 |
| Gross Profit | 7.0 | 28.1 | 31.1 | 28.5 | 46.3 | 21.7 | 66.6 |
| Operating Expenses | |||||||
| R&D Expenses | 681.8 | 550.4 | 439.9 | 454.1 | 483.0 | 236.6 | 263.2 |
| SG&A Expenses | 610.5 | 591.4 | 416.1 | 383.4 | 775.0 | 259.9 | 335.8 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 596.1 | 0 |
| Operating Expenses | 1,292.3 | 1,141.8 | 856.0 | 837.5 | 1,258.1 | 1,092.6 | 599.0 |
| Operating Income | |||||||
| Operating Income | (1,285.3) | (1,113.7) | (824.9) | (809.0) | (1,211.7) | (1,070.9) | (532.4) |
| Interest Expense | 0 | 0 | 34.8 | 28.0 | 7.0 | 2.8 | 7.7 |
| Interest Income | 178.1 | 258.4 | 146.4 | 32.2 | 0.4 | 1.4 | 18.0 |
| Profitability | |||||||
| EBITDA | (1,282.0) | (1,099.6) | (802.9) | (790.2) | (910.8) | (895.7) | (553.3) |
| EBIT | (1,285.3) | (1,113.7) | (824.9) | (809.0) | (916.7) | (895.7) | (553.3) |
| Income Before Tax | (264.6) | (681.6) | 4,567.9 | (885.0) | (923.7) | (898.5) | (561.0) |
| Income Tax Expense | 133.3 | 48.2 | 21.5 | 4.1 | 0.4 | 1.7 | 7.1 |
| Net Income | (299.8) | (172.0) | 4,348.9 | (1,009.0) | (845.3) | (809.2) | 1,200.5 |
| Per Share Data | |||||||
| EPS (Basic) | -0.43 | -0.24 | 5.55 | -1.42 | -1.26 | -1.18 | 1.75 |
| EPS (Diluted) | -0.43 | -0.24 | 5.23 | -1.42 | -1.26 | -1.18 | 1.75 |
| Shares Outstanding | 693.9 | 725.4 | 783.2 | 712.8 | 669.8 | 684.8 | 684.8 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 1,423.1 | 2,715.4 | 6,535.7 | 1,676.8 | 2,060.4 | 2,132.7 | 2,185.5 |
| Short-Term Investments | 2,872.6 | 2,171.5 | 5.4 | 5.0 | 0 | 0 | 0 |
| Net Receivables | 789.8 | 0 | 82.8 | 37.6 | 6.7 | 13.8 | 15.3 |
| Inventory | 0 | 0 | 35.3 | 2.8 | 0 | 0 | 0 |
| Other Current Assets | 81.9 | 113.2 | 17.6 | 20.4 | 26.0 | 0.9 | 2.1 |
| Total Current Assets | 5,167.4 | 5,000.1 | 6,731.8 | 1,798.6 | 2,146.5 | 2,187.0 | 2,219.2 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 92.4 | 101.1 | 66.0 | 92.3 | 86.9 | 77.0 | 73.9 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 137.8 | 144.9 | 0 | 0 | 0 |
| Long-Term Investments | 415.9 | 302.9 | 247.8 | 304.3 | 325.8 | 398.5 | 177.2 |
| Other Non-Current Assets | 33.0 | 32.9 | 39.1 | 49.5 | 25.8 | 27.2 | 6.7 |
| Total Non-Current Assets | 560.7 | 436.9 | 490.7 | 591.0 | 438.6 | 502.7 | 257.8 |
| Total Assets | 5,728.0 | 5,436.9 | 7,222.5 | 2,389.6 | 2,585.1 | 2,689.7 | 2,477.1 |
| Current Liabilities | |||||||
| Account Payables | 18.0 | 23.7 | 53.2 | 37.8 | 34.6 | 20.6 | 10.3 |
| Short-Term Debt | 11.1 | 9.8 | 12 | 40.7 | 0 | 12.3 | 7.8 |
| Deferred Revenue | 0 | 1.2 | 4.2 | 12.4 | 10.1 | 5.9 | 3.6 |
| Other Current Liabilities | 119.1 | 53.9 | 85.9 | 74.8 | 84.0 | 141.4 | 39.7 |
| Total Current Liabilities | 281.2 | 149.4 | 266.8 | 272.4 | 184.4 | 219.0 | 92.1 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 0 | 0 | 430.6 | 375.5 | 210.0 | 170.3 | 108.6 |
| Deferred Tax Liabilities | 19.4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 38.7 | 10.0 | 29.3 | 80.6 | 53.1 | 76.1 | 103.2 |
| Total Non-Current Liabilities | 154.4 | 100.3 | 507.2 | 509.6 | 339.3 | 308.7 | 276.2 |
| Total Liabilities | 435.6 | 249.7 | 774.0 | 782.0 | 523.7 | 527.7 | 368.4 |
| Stockholders' Equity | |||||||
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (501.8) | 116.1 | 576.2 | (3,772.8) | (2,763.7) | (1,918.5) | (1,109.2) |
| Accumulated Other Comprehensive Income | 4.4 | 9.4 | (4.1) | (2.6) | (0.9) | 1.4 | (2.3) |
| Total Stockholders' Equity | 4,527.4 | 4,687.6 | 5,968.6 | 1,157.8 | 1,656.9 | 1,897.8 | 2,032.2 |
| Total Liabilities & Equity | 5,728.0 | 5,436.9 | 7,222.5 | 2,389.6 | 2,585.1 | 2,689.7 | 2,477.1 |
| Debt Metrics | |||||||
| Total Debt | 107.4 | 100.2 | 499.7 | 481.4 | 283.9 | 245.0 | 180.9 |
| Net Debt | (1,315.7) | (2,615.2) | (6,036.0) | (1,195.4) | (1,776.5) | (1,887.8) | (2,004.6) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (397.9) | (356.7) | 4,231.2 | (1,115.5) | (924.1) | (900.2) | (519.4) |
| Depreciation & Amortization | 3.3 | 14.1 | 22.0 | 18.9 | 5.9 | 0 | 0 |
| Stock-Based Compensation | 346.2 | 289.0 | 199.6 | 217.8 | 565.0 | 85.0 | 0 |
| Change in Working Capital | (621.8) | (77.0) | 19.0 | 6.3 | 15.7 | 71.9 | 15.3 |
| Other Non-Cash Items | (80.2) | (708.8) | (5,237.2) | 29.1 | (340.2) | 191.2 | (257.7) |
| Operating Cash Flow | (750.3) | (839.5) | (765.3) | (843.4) | (677.7) | (552.1) | (761.8) |
| Investing Activities | |||||||
| Capital Expenditure | (8.2) | (4.6) | (1.4) | (12.7) | (17.4) | (5.8) | (4.9) |
| Acquisitions | 0 | 229.4 | (37.0) | 107.9 | (0.0) | 0 | 1,771.7 |
| Purchases of Investments | 0 | (4,061.5) | 0 | 0 | 0 | 0 | (68.4) |
| Sales/Maturities of Investments | (37.5) | 1,960 | 0 | 0 | 320.2 | 0 | 16.4 |
| Other Investing Activities | (636.6) | 110.5 | 5,242.0 | (139.4) | 0.6 | (25.9) | (20.0) |
| Investing Cash Flow | (682.3) | (1,766.3) | 5,203.6 | (44.3) | 303.3 | (31.7) | 1,694.8 |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | (52.8) | (30.7) | 129.8 | 14.8 | 0 | (32.1) |
| Stock Repurchased | (318.1) | (1,293.2) | 0 | 0 | 0 | 0 | (1,188.5) |
| Dividends Paid | 0 | 0 | (6) | 0 | 0 | 0 | 0 |
| Other Financing Activities | (9.4) | 13.4 | 17.5 | (10.0) | 292.0 | 0.5 | 83.5 |
| Financing Cash Flow | 134.2 | (1,219.8) | 419.4 | 499.5 | 306.8 | 456.3 | 217.2 |
| Cash Position | |||||||
| Net Change in Cash | (1,294.7) | (3,824.8) | 4,858.3 | (381.9) | (67.6) | (127.6) | 1,335.9 |
| Cash at Beginning | 2,725.7 | 6,550.4 | 1,692.1 | 2,074.0 | 2,141.7 | 2,269.3 | 849.6 |
| Cash at End | 1,431.0 | 2,725.7 | 6,550.4 | 1,692.1 | 2,074.0 | 2,141.7 | 2,185.5 |
| Free Cash Flow | (758.6) | (844.0) | (766.6) | (856.1) | (695.2) | (557.9) | (766.7) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 8.3 | 29.1 | 32.7 | 31.5 | 55.3 | 23.8 | 67.7 |
| Gross Profit | 7.0 | 28.1 | 31.1 | 28.5 | 46.3 | 21.7 | 66.6 |
| Operating Income | (1,285.3) | (1,113.7) | (824.9) | (809.0) | (1,211.7) | (1,070.9) | (532.4) |
| Net Income | (299.8) | (172.0) | 4,348.9 | (1,009.0) | (845.3) | (809.2) | 1,200.5 |
| EPS (Diluted) | -0.43 | -0.24 | 5.23 | -1.42 | -1.26 | -1.18 | 1.75 |
| Balance Sheet | |||||||
| Cash & Equivalents | 1,423.1 | 2,715.4 | 6,535.7 | 1,676.8 | 2,060.4 | 2,132.7 | 2,185.5 |
| Total Assets | 5,728.0 | 5,436.9 | 7,222.5 | 2,389.6 | 2,585.1 | 2,689.7 | 2,477.1 |
| Total Debt | 107.4 | 100.2 | 499.7 | 481.4 | 283.9 | 245.0 | 180.9 |
| Stockholders' Equity | 4,527.4 | 4,687.6 | 5,968.6 | 1,157.8 | 1,656.9 | 1,897.8 | 2,032.2 |
| Cash Flow | |||||||
| Operating Cash Flow | (750.3) | (839.5) | (765.3) | (843.4) | (677.7) | (552.1) | (761.8) |
| Capital Expenditure | (8.2) | (4.6) | (1.4) | (12.7) | (17.4) | (5.8) | (4.9) |
| Free Cash Flow | (758.6) | (844.0) | (766.6) | (856.1) | (695.2) | (557.9) | (766.7) |